title: [A questionnaire survey about hair loss after chemotherapy for breast cancer].
abstract: Hair loss is one of the most common side effects of chemotherapies such as FEC and taxane, and it greatly affects quality of life. We conducted a questionnaire survey of breast cancer patients who were treated with adjuvant chemotherapy about their hair loss. Eighty-five patients participated. They all had lost their hair and suffered from persistent changes in their hair condition, ranging from thinning to curly. More than 80% of patients had worn wigs until their hair had grown back. Furthermore, a few patients did not remove their wigs for 2 years after treatment. Unfortunately, there is no prevention or medication to combat hair loss due to chemotherapy at present, so cumulative examinations are awaited. We must provide appropriate information and support to the patient.
authors.affiliation: Dept. of Surgery, Sendai Medical Center.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Oshima
authors.forename: Takanori
authors.initials: T
authors.lastname: Watanabe
authors.forename: Saki
authors.initials: S
authors.lastname: Nakagawa
authors.forename: Ayako
authors.initials: A
authors.lastname: Endo
authors.forename: Chizuko
authors.initials: C
authors.lastname: Shiga
mesh_terms: D000328:Adult; D000505:Alopecia / Q000139:chemically induced* / Q000523:psychology; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006197:Hair / Q000033:anatomy & histology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents